Alnylam Pharmaceuticals
ALNY
#575
Rank
A$56.31 B
Marketcap
$436.62
Share price
-2.11%
Change (1 day)
64.12%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company